Yes, this is true. In March 2019, Sanofi announced that it would reduce the cost of its most often prescribed insulin, Lantus, from $270 to $99 per box. This represents a reduction of 78%.
We talk about the MARKET
Yes, this is true. In March 2019, Sanofi announced that it would reduce the cost of its most often prescribed insulin, Lantus, from $270 to $99 per box. This represents a reduction of 78%.